116 related articles for article (PubMed ID: 29721156)
1. Pro-tumoral immune cell alterations in wild type and
Li X; Singh K; Luo Z; Mejia-Cordova M; Jamalpour M; Lindahl B; Zhang G; Sandler S; Welsh M
Oncotarget; 2018 Apr; 9(27):18720-18733. PubMed ID: 29721156
[TBL] [Abstract][Full Text] [Related]
2. Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts.
Zang G; Gustafsson K; Jamalpour M; Hong J; Genové G; Welsh M
BMC Cancer; 2015 Apr; 15():234. PubMed ID: 25885274
[TBL] [Abstract][Full Text] [Related]
3. Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in
He Q; Jamalpour M; Bergquist E; Anderson RL; Gustafsson K; Welsh M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768912
[TBL] [Abstract][Full Text] [Related]
4. Disparate effects of Shb gene deficiency on disease characteristics in murine models of myeloid, B-cell, and T-cell leukemia.
Jamalpour M; Li X; Gustafsson K; Tyner JW; Welsh M
Tumour Biol; 2018 Apr; 40(4):1010428318771472. PubMed ID: 29792386
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
6. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells.
Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M
Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesis.
Åkerblom B; Zang G; Zhuang ZW; Calounova G; Simons M; Welsh M
Mol Oncol; 2012 Jun; 6(3):333-46. PubMed ID: 22336752
[TBL] [Abstract][Full Text] [Related]
8. Shb deficiency in endothelium but not in leucocytes is responsible for impaired vascular performance during hindlimb ischaemia.
Nikpour M; Gustafsson K; Vågesjö E; Seignez C; Giraud A; Phillipson M; Welsh M
Acta Physiol (Oxf); 2015 Jun; 214(2):200-9. PubMed ID: 25561022
[TBL] [Abstract][Full Text] [Related]
9. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis.
Chopra M; Riedel SS; Biehl M; Krieger S; von Krosigk V; Bäuerlein CA; Brede C; Jordan Garrote AL; Kraus S; Schäfer V; Ritz M; Mattenheimer K; Degla A; Mottok A; Einsele H; Wajant H; Beilhack A
Carcinogenesis; 2013 Jun; 34(6):1296-303. PubMed ID: 23385062
[TBL] [Abstract][Full Text] [Related]
11. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
[TBL] [Abstract][Full Text] [Related]
12. Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes.
Pilones KA; Aryankalayil J; Babb JS; Demaria S
J Immunother Cancer; 2014; 2(1):37. PubMed ID: 25349699
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional microvasculature as a consequence of shb gene inactivation causes impaired tumor growth.
Funa NS; Kriz V; Zang G; Calounova G; Akerblom B; Mares J; Larsson E; Sun Y; Betsholtz C; Welsh M
Cancer Res; 2009 Mar; 69(5):2141-8. PubMed ID: 19223532
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
17. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
[TBL] [Abstract][Full Text] [Related]
18. Immune compartmentalization of T cell subsets in chemically-induced breast cancer.
Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D
Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
[TBL] [Abstract][Full Text] [Related]
20. TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases.
Ham B; Wang N; D'Costa Z; Fernandez MC; Bourdeau F; Auguste P; Illemann M; Eefsen RL; Høyer-Hansen G; Vainer B; Evrard M; Gao ZH; Brodt P
Cancer Res; 2015 Dec; 75(24):5235-47. PubMed ID: 26483205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
